SCHEMBL28527366

SCHEMBL28527366

COc1ccc(-c2n[c]c[nH]2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
MPI P34949 1/20 0.46
GFER P55789 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
SCN2A Q99250 1/20 0.45
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ATM Q13315 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2094695 0.81 ALDH1A1 (0.45) KDM4EALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL2653005 0.80 DCUN1D1 (0.49) ALDH1A1GAASMN1; SMN2CLK4AURKA
SCHEMBL2651782 0.79 DRD1 (0.42) ALDH1A1GAAHPGDGFERNPC1
SCHEMBL17626003 0.75 KDM4E (0.41) KDM4EALDH1A1GAAHPGDSCN2A
SCHEMBL4049587 0.75 ALDH1A1 (0.41) KDM4EALDH1A1GAAHPGDAPOBEC3G
SCHEMBL2652005 0.75 SMN1; SMN2 (0.38) KDM4EALDH1A1GAAHPGDGFER
SCHEMBL4047558 0.75 DGAT1 (0.37) ALDH1A1NPC1RAB9ASMN1; SMN2ATM
SCHEMBL403894 0.74 MTOR (0.43) KDM4EALDH1A1GAASCN2ANPC1
SCHEMBL27876872 0.72 KDM4E (0.48) KDM4EALDH1A1GAAHPGDMPI
SCHEMBL6616595 0.70 KDM4E (0.49) KDM4EALDH1A1GAAHPGDMPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117396505-A Methods of treating inflammation 维鲁公司 2024-01-12 CN disclosed
CN-115379835-A Methods of treating coronavirus 维鲁公司 2022-11-22 CN disclosed
CN-112512522-A Compounds for the treatment of triple negative breast and ovarian cancer 田纳西大学研究基金会 2021-03-16 CN disclosed
CN-112437664-A Compounds for the treatment of pancreatic cancer 田纳西大学研究基金会 2021-03-02 CN disclosed